MediciNova, Inc. (MNOV) Social Stream
MEDICINOVA INC (MNOV) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering MEDICINOVA INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 3 | $27 | $10 | $16.5 | $2.09 | 689.47% |
| 2022-03-01 | 3 | $27 | $6 | $14.333 | $2.09 | 585.79% |
| 2022-04-06 | 1 | $27 | $6 | $14.333 | $2.09 | 585.79% |
| 2022-08-19 | 2 | $27 | $6 | $13 | $2.09 | 522.01% |
| 2023-02-27 | 3 | $27 | $6 | $13 | $2.09 | 522.01% |
| 2023-05-30 | 2 | $27 | $6 | $16.5 | $2.09 | 689.47% |
| 2023-08-21 | 2 | $26 | $6 | $16 | $2.09 | 665.55% |
The Trend in the Analyst Price Target
Over the past 25 months, MNOV's average price target has gone down $2.
MNOV reports an average of 561.93% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-27 | 2 | 27 | 6 | 16.5 | 2.21 | 646.61% |
| 2023-02-27 | 3 | 27 | 6 | 13.0 | 2.21 | 488.24% |
| 2023-02-27 | 3 | 27 | 6 | 16.5 | 2.21 | 646.61% |
| 2023-08-21 | 2 | 26 | 6 | 16.0 | 2.36 | 577.97% |
| 2023-08-21 | 1 | 26 | 6 | 16.0 | 2.36 | 577.97% |
MNOV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
MNOV's average broker recommendation rating improved by 0 over the prior 15 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MNOV as an investment opportunity.
- MNOV has a greater number of analysts covering the stock than 43.96% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, MEDICINOVA INC's upside potential (average analyst target price relative to current price) is greater than 1036.06% of them.
- To contextualize these metrics, consider that out of all US stocks, MEDICINOVA INC's variance in analysts' estimates is lower than -934.83% of them.
- MEDICINOVA INC's average analyst price target is greater than 295.72% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MEDICINOVA INC are SVRA, BPTH, and ONTX.
View All Top Stocks by Price Target
Is MNOV a Buy, Hold or Sell? See the POWR Ratings now!